½ÃÀ庸°í¼­
»óǰÄÚµå
1575481

¼¼°èÀÇ È²»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Enilconazole sulfate Market by Application (Agriculture, Pharmaceuticals, Veterinary Medicine), End User (Farmers, Pharmaceutical Companies, Veterinarians), Formulation, Distribution Channel - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ȳ»ê¿¡´ÒÄÚ³ªÁ¹(Enilconazole sulfate) ½ÃÀåÀº 2023³â¿¡ 20¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 21¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 6.82%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 32¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ȳ»ê¿¡´ÒÄÚ³ªÁ¹Àº ƯÈ÷ °¡Ãà°ú ¹Ý·Áµ¿¹°ÀÇ ´Ù¾çÇÑ °õÆÎÀÌ °¨¿°À» Ä¡·áÇϱâ À§ÇØ ¼öÀÇÇп¡¼­ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â Ç×Áø±ÕÁ¦ÀÔ´Ï´Ù. Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀåÀº ÁÖ·Î µ¿¹°ÀÇ °õÆÎÀÌ °¨¿° ¹ß»ý·ü Áõ°¡, ¹Ý·Áµ¿¹° º¸À¯À² Áõ°¡, È¿°úÀûÀÎ µ¿¹°¿ë ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Ȳ»ê¼ÖÀº ÇǺκ´ ¹× Àü½Å °¨¿°À» Áß½ÉÀ¸·Î ¼öÀÇÇÐ Àü¹Ý¿¡ °ÉÃÄ »ç¿ëµÇ°í ÀÖÀ¸¸ç, ³óÀÛ¹°¿¡ ´ëÇÑ µ¿Á¾¿ä¹ý ¿ëµµ·Î ³ó¾÷ ºÐ¾ß¿¡¼­µµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ë ¹üÀ§´Â ÁÖ·Î µ¿¹° º´¿ø, Ãà»ê ºÐ¾ß ¹× ³ó¾÷ ºÐ¾ß¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÁÖ¿ä ¼ºÀå µ¿·ÂÀ¸·Î´Â µ¿¹° °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä È®´ë, ¼öÀÇÇÐ Ä¡·áÀÇ ¹ßÀü, µ¿¹° º¹Áö ±âÁØ¿¡ ´ëÇÑ ±ÔÁ¦ °­È­ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ó¾÷ ºÐ¾ß¿¡¼­ ÀÚ¿¬¿ä¹ý ¹× µ¿Á¾¿ä¹ý Ä¡·á¹ýÀÇ Áö¼ÓÀûÀÎ Ãß¼¼´Â ½ÃÀå ħÅõ·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ ±âȸ´Â ÇǺΠũ¸²À̳ª °æ±¸¿ë ¼Ö·ç¼Ç°ú °°ÀÌ ´õ Á¢±ÙÇϱ⠽±°í ´ú ħ½ÀÀûÀÎ Àü´Þ ½Ã½ºÅÛÀ» °³¹ßÇÏ¿© ¼øÀÀµµ¿Í °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡Ãà »ý»êÀÌ Áõ°¡ÇÏ´Â Áö¿ª°ú ³ó¾÷ °üÇàÀÌ È®´ëµÇ´Â ½ÃÀå¿¡¼­µµ ÀáÀç·ÂÀÌ ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ µµÀü °úÁ¦¿¡´Â »ç¿ë°ú °ü·ÃµÈ ÀáÀçÀû ºÎÀÛ¿ë ¹× µ¶¼º ¹®Á¦, ³»¼º °³¹ß, ¾ö°ÝÇÑ ±ÔÁ¦ Àå¾Ö¹° µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ëü Ç×Áø±ÕÁ¦¿ÍÀÇ °æÀï°ú Áö¿ªº° ±ÔÁ¦ ȯ°æÀÇ º¯È­µµ ½ÃÀå È®´ë¸¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Çõ½Å ºÐ¾ß¿¡´Â È¿´ÉÀ» °³¼±ÇÏ°í ºÎÀÛ¿ëÀ» ÁÙÀ̱â À§ÇÑ ´õ ³ªÀº ÇÕ¼º °øÁ¤°ú º¸´Ù Ç¥ÀûÈ­µÈ Àû¿ëÀ» À§ÇÑ Ã·´Ü Àü´Þ ½Ã½ºÅÛÀÌ Æ÷ÇԵ˴ϴÙ. Àü¹ÝÀûÀ¸·Î ÀÌ ½ÃÀåÀº °æÀïÀÌ Àû´çÈ÷ Ä¡¿­Çϸç, ¼öÀÇÇÐ ºÎ¹®¿¡¼­ ²ÙÁØÇÑ ¼ö¿ä°¡ ¹ß»ýÇÏ°í ³ó¾÷ ºÐ¾ß·Î ´Ù°¢È­ÇÒ ¿©Áö°¡ ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ±â¾÷Àº ³»¼º ¹× ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀ» ÇØ°áÇϱâ À§ÇØ ¼öÀÇÇÐ ±â°ü ¹× ³ó¾÷ ±â°ü°úÀÇ °øµ¿ ¿¬±¸¸¦ ¸ð»öÇÏ¿© »õ·Î¿î ÀÀ¿ë ºÐ¾ß¸¦ À°¼ºÇϰí Ä¡·á È¿´ÉÀ» Çâ»ó½ÃÅ´À¸·Î½á ½ÃÀå Á¡À¯À²À» È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ¿ªµ¿ÀûÀΠƯ¼ºÀ¸·Î ÀÎÇØ Áö¼ÓÀûÀÎ ¼ºÀåÀ» À§Çؼ­´Â ¼öÀÇÇÐ ¹× ³ó¾÷ ºÐ¾ßÀÇ ±ÔÁ¦ º¯È­¿Í ¹ßÀüÀ» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 20¾ï 3,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 21¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 32¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 6.82%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­Çϴ Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ó¾÷ ¹× ¼öÀÇÇÐ ºÐ¾ß¿¡¼­ È¿°úÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÑ Áø±Õ °¨¿°ÀÇ À¯º´·ü Áõ°¡
    • ³óÀÛ¹°À̳ª µ¿¹°¿¡ ´ëÇÑ ³»¼º Áø±Õ°ú ½Î¿ì±â À§ÇÑ ±¤¿ª Ç×Áø±ÕÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ³óÀÛ¹° ¼öÀ² Çâ»óÀ» À§ÇÑ »ì±ÕÁ¦ Ä¡·áÀÇ º¸±ÞÀ» µÞ¹ÞħÇÏ´Â ³ó¾÷ ±â¼ú Áøº¸
    • ½Äǰ ¹× »ç·áÀÇ ¾ÈÀü ±âÁØÀ» È®º¸Çϱâ À§ÇØ, ƯÁ¤ÀÇ »ì±ÕÁ¦ÀÇ »ç¿ëÀ» Àǹ«È­ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ÀÇ ÀåÁ¡°ú ¿ëµµ¿¡ °üÇÑ ÃÖÁ¾ »ç¿ëÀÚÀÇ Àνİú Áö½ÄÀÌ ÇÑÁ¤ÀûÀÎ °Í
    • ´ëü Ç×Áø±ÕÁ¦¿ÍÀÇ °æÀïÀº µ¿¹°¼º ½ÃÀå¿¡¼­ Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ÀÇ Á¡À¯À²À» Á¦ÇÑ
  • ½ÃÀå ±âȸ
    • Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ÀÇ Áø±Õº´¿¡ ´ëÇÑ È¿´É¿¡ ÀÇÇÑ ÀÛ¹° º¸È£¿¡ ´ëÇÑ ÀÀ¿ë È®´ë
    • Ȳ»ê¿¡´ÒÄÚ³ªÁ¹°ú ´Ù¸¥ ³ó¾à°úÀÇ ½Ã³ÊÁö È¿°ú¿¡ ÀÇÇÑ »õ·Î¿î ½ÃÀå °³Ã´
    • Áö¼Ó °¡´ÉÇÑ ³ó¹ý¿¡ ÀÇÇØ »ì±ÕÁ¦·Î¼­ Ȳ»ê¿¡´ÒÄÚ³ªÁ¹¿¡ ´ëÇÑ ½Å·Ú Áõ°¡
  • ½ÃÀå °úÁ¦
    • Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå¿¡¼­ °¡°Ý °æÀïÀ¸·Î À̾îÁö´Â ÈĹßǰ°úÀÇ °æÀï °ÝÈ­
    • ³ó¾÷¿ëµµ¿¡ ´ëÇÑ È²»ê¿¡´ÒÄÚ³ªÁ¹ÀÇ »ç¿ë¿¡ ¼ö¹ÝÇϴ ȯ°æ ¹× °Ç°­¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ ã±â

Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø ¹× Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °õÆÎÀÌ °¨¿°ÀÇ È®»êÀº È®´ëµÇ°í ³ó¾÷ ¹× ¼öÀÇÇÐ ºÐ¾ß¿¡¼­ È¿°úÀûÀÎ Ä¡·á°¡ ÇÊ¿ä
      • ÀÛ¹°À̳ª µ¿¹°ÀÇ ³»¼º±ÕÁÖ¿¡ ´ëÇ×Çϱâ À§ÇÑ ±¤¿ª ½ºÆåÆ®·³ Ç×Áø±ÕÁ¦ ¼ö¿ä Áõ°¡
      • ³ó¾÷ ±â¼ú Áøº¸¿¡ ÀÇÇØ ÀÛ¹°ÀÇ ¼öÈ®·®À» ´Ã¸®±â À§ÇÑ »ì±ÕÁ¦ ó¸®ÀÇ µµÀÔÀÌ ÃËÁø
      • ½Äǰ ¹× »ç·áÀÇ ¾ÈÀü ±âÁØÀ» È®º¸Çϱâ À§Çؼ­ ƯÁ¤ »ì±ÕÁ¦ÀÇ »ç¿ëÀ» Àǹ«È­ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
    • ¾ïÁ¦¿äÀÎ
      • Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ÀÇ ÀåÁ¡°ú ¿ëµµ¿¡ °üÇÑ ÃÖÁ¾ »ç¿ëÀÚÀÇ Àνİú Áö½ÄÀÌ ÇÑÁ¤Àû
      • ´ëü Ç×Áø±ÕÁ¦¿ÍÀÇ °æÀïÀº ¼öÀÇ»ç ÀÀ¿ë¿¡¼­ Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå Á¡À¯À²À» Á¦ÇÑ
    • ±âȸ
      • Áø±Õ¼º Áúȯ¿¡ ´ëÇÑ È¿´É¿¡ ÀÇÇØ ÀÛ¹° º¸È£¿¡ ´ëÇÑ È²»ê¿¡´ÒÄÚ³ªÁ¹ÀÇ Àû¿ëÀÌ È®´ë
      • Ȳ»ê¿¡´ÒÄÚ³ªÁ¹°ú ´Ù¸¥ ³ó¾à°úÀÇ ½Ã³ÊÁö È¿°ú¿¡ ÀÇÇØ »õ·Î¿î ½ÃÀå °³Ã´ÀÌ °¡´É
      • Áö¼Ó °¡´ÉÇÑ ³ó¾÷ °üÇà¿¡ ÀÇÇØ ¿ì¼± »ì±ÕÁ¦·Î¼­ Ȳ»ê¿¡´ÒÄÚ³ªÁ¹¿¡ ´ëÇÑ ÀÇÁ¸ÀÌ Áõ°¡
    • °úÁ¦
      • Á¦³×¸¯ ÀǾàǰ°úÀÇ °æÀïÀÌ Ä¡¿­ ÇØÁö°í °¡°Ý °æÀï °ÝÈ­
      • ³ó¾÷¿ëµµ¿¡¼­ Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ÀÇ »ç¿ë°ú °ü·ÃµÈ ȯ°æ ¹× °Ç°­»óÀÇ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå : ¿ëµµº°

  • ³ó¾÷
    • »ì±ÕÁ¦
    • »ì±ÕÁ¦
    • Á¦ÃÊÁ¦
  • ÀǾàǰ
    • Ç×±Õ ¿¬°í
    • Ç×Áø±Õ Å©¸²
  • ¼öÀÇÇÐ
    • °æ±¸ Ä¡·á
    • ±¹¼Ò Ä¡·á

Á¦7Àå Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ³ó¹Î
    • ´ë±Ô¸ð ³ó°¡
    • ¼Ò±Ô¸ð ³ó°¡
  • Á¦¾àȸ»ç
    • ¸®¼¿·¯
    • Á¦Á¶¾÷ü
  • ¼öÀÇ»ç
    • Ŭ¸®´Ð º£À̽º
    • ÇÊµå º£À̽º

Á¦8Àå Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå : ó¹æº°

  • ¾×ü
    • ³óÃà¾×
    • ¹Ù·Î »ç¿ëÇÒ ¼ö ÀÖ´Â ¾×ü
  • ºÐ¸»
    • Á÷Á¢ µµÆ÷ ÆÄ¿ì´õ
    • ¼ö¿ë¼º ºÐ¸»

Á¦9Àå Ȳ»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ ÆÇ¸Å
    • ¼Ò¸ÅÁ¡
    • µµ¸Å¾÷ü
  • ¿Â¶óÀÎ ÆÇ¸Å
    • ±â¾÷ À¥»çÀÌÆ®
    • ÀüÀÚ»ó°Å·¡ Ç÷§Æû

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ È²»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ È²»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ È²»ê¿¡´ÒÄÚ³ªÁ¹ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È
LYJ

The Enilconazole sulfate Market was valued at USD 2.03 billion in 2023, expected to reach USD 2.17 billion in 2024, and is projected to grow at a CAGR of 6.82%, to USD 3.23 billion by 2030.

Enilconazole sulfate is an antifungal agent commonly used in veterinary medicine to treat a variety of fungal infections, particularly in livestock and companion animals. The market for enilconazole sulfate is driven by several factors, primarily the increasing incidences of fungal infections in animals, rising pet ownership, and the demand for effective veterinary drugs. Its applications span across veterinary medicine, focusing on dermatological and systemic infections, along with its use in agriculture as a homeopathic application for crops. The end-use scope predominantly includes veterinary clinics, animal husbandry sectors, and agricultural fields. Key growth drivers include expanding awareness regarding animal health, advancement in veterinary care, and heightened regulations on animal welfare standards. Furthermore, the ongoing trend of natural and homeopathic treatment methods in agriculture enhances its market penetration. A notable opportunity lies in developing more accessible and less invasive delivery systems, such as dermal creams or oral solutions, to enhance compliance and outcomes. There's also potential in regions with increasing livestock production and in markets with expanding agricultural practices. Challenges in the market include potential side effects and toxicity concerns associated with its use, resistance development, and stringent regulatory hurdles. Additionally, competition from alternative antifungal treatments and variations in regional regulatory landscapes can hinder market expansion. Innovation areas include better synthesis processes to improve potency and reduce side effects, and advanced delivery systems for more targeted application. Overall, the market is moderately competitive, characterized by steady demand driven by the veterinary sector with scope for diversification into agriculture. Businesses can explore collaborative research with veterinary institutions and agricultural bodies to address resistance and safety profiles, thereby expanding market share by fostering novel applications and enhancing therapeutic efficacy. The dynamic nature of the market necessitates continuous monitoring of regulatory changes and advances in veterinary and agricultural practices to sustain growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.03 billion
Estimated Year [2024] USD 2.17 billion
Forecast Year [2030] USD 3.23 billion
CAGR (%) 6.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enilconazole sulfate Market

The Enilconazole sulfate Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of fungal infections necessitating effective treatments in agricultural and veterinary sectors
    • Rising demand for broad-spectrum antifungal agents to combat resistant fungal strains in crops and animals
    • Technological advancements in agricultural practices boosting adoption of fungicide treatments for enhanced crop yield
    • Stringent regulatory frameworks mandating the use of specific fungicides to ensure food and feed safety standards
  • Market Restraints
    • Limited awareness and knowledge among end-users about the benefits and applications of enilconazole sulfate
    • Competition from alternative antifungal agents could limit the market share of enilconazole sulfate in veterinary applications
  • Market Opportunities
    • Expanding application of enilconazole sulfate in crop protection due to its effectiveness against fungal diseases
    • Synergistic effects of enilconazole sulfate with other agrochemicals creating new market avenues
    • Sustainable farming practices increasing reliance on enilconazole sulfate as a preferred fungicide
  • Market Challenges
    • Increasing competition from generic alternatives leading to price wars in the enilconazole sulfate market
    • Environmental and health concerns associated with the use of enilconazole sulfate in agricultural applications

Porter's Five Forces: A Strategic Tool for Navigating the Enilconazole sulfate Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enilconazole sulfate Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enilconazole sulfate Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enilconazole sulfate Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enilconazole sulfate Market

A detailed market share analysis in the Enilconazole sulfate Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enilconazole sulfate Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enilconazole sulfate Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enilconazole sulfate Market

A strategic analysis of the Enilconazole sulfate Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enilconazole sulfate Market, highlighting leading vendors and their innovative profiles. These include ADAMA Agricultural Solutions Ltd., Albaugh, LLC, American Vanguard Corporation, Arysta LifeScience Corporation, BASF SE, Bayer AG, Cheminova A/S, Corteva Agriscience, Dhanuka Agritech Limited, Dow Chemical Company, FMC Corporation, Isagro SpA, Koppert Biological Systems, Marrone Bio Innovations, Inc., Nissan Chemical Corporation, Nufarm Limited, Sumitomo Chemical Co., Ltd., Syngenta AG, UPL Limited, and Valent U.S.A. LLC.

Market Segmentation & Coverage

This research report categorizes the Enilconazole sulfate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Agriculture, Pharmaceuticals, and Veterinary Medicine. The Agriculture is further studied across Bactericides, Fungicides, and Herbicides. The Pharmaceuticals is further studied across Antibacterial Ointments and Antifungal Creams. The Veterinary Medicine is further studied across Oral Treatments and Topical Treatments.
  • Based on End User, market is studied across Farmers, Pharmaceutical Companies, and Veterinarians. The Farmers is further studied across Large-Scale Farmers and Small-Scale Farmers. The Pharmaceutical Companies is further studied across Distributors and Manufacturers. The Veterinarians is further studied across Clinic-Based and Field-Based.
  • Based on Formulation, market is studied across Liquid and Powder. The Liquid is further studied across Concentrated Liquids and Ready-To-Use Liquids. The Powder is further studied across Direct Application Powders and Water-Soluble Powders.
  • Based on Distribution Channel, market is studied across Offline Sales and Online Sales. The Offline Sales is further studied across Retail Stores and Wholesalers. The Online Sales is further studied across Company Websites and E-Commerce Platforms.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of fungal infections necessitating effective treatments in agricultural and veterinary sectors
      • 5.1.1.2. Rising demand for broad-spectrum antifungal agents to combat resistant fungal strains in crops and animals
      • 5.1.1.3. Technological advancements in agricultural practices boosting adoption of fungicide treatments for enhanced crop yield
      • 5.1.1.4. Stringent regulatory frameworks mandating the use of specific fungicides to ensure food and feed safety standards
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and knowledge among end-users about the benefits and applications of enilconazole sulfate
      • 5.1.2.2. Competition from alternative antifungal agents could limit the market share of enilconazole sulfate in veterinary applications
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding application of enilconazole sulfate in crop protection due to its effectiveness against fungal diseases
      • 5.1.3.2. Synergistic effects of enilconazole sulfate with other agrochemicals creating new market avenues
      • 5.1.3.3. Sustainable farming practices increasing reliance on enilconazole sulfate as a preferred fungicide
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing competition from generic alternatives leading to price wars in the enilconazole sulfate market
      • 5.1.4.2. Environmental and health concerns associated with the use of enilconazole sulfate in agricultural applications
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enilconazole sulfate Market, by Application

  • 6.1. Introduction
  • 6.2. Agriculture
    • 6.2.1. Bactericides
    • 6.2.2. Fungicides
    • 6.2.3. Herbicides
  • 6.3. Pharmaceuticals
    • 6.3.1. Antibacterial Ointments
    • 6.3.2. Antifungal Creams
  • 6.4. Veterinary Medicine
    • 6.4.1. Oral Treatments
    • 6.4.2. Topical Treatments

7. Enilconazole sulfate Market, by End User

  • 7.1. Introduction
  • 7.2. Farmers
    • 7.2.1. Large-Scale Farmers
    • 7.2.2. Small-Scale Farmers
  • 7.3. Pharmaceutical Companies
    • 7.3.1. Distributors
    • 7.3.2. Manufacturers
  • 7.4. Veterinarians
    • 7.4.1. Clinic-Based
    • 7.4.2. Field-Based

8. Enilconazole sulfate Market, by Formulation

  • 8.1. Introduction
  • 8.2. Liquid
    • 8.2.1. Concentrated Liquids
    • 8.2.2. Ready-To-Use Liquids
  • 8.3. Powder
    • 8.3.1. Direct Application Powders
    • 8.3.2. Water-Soluble Powders

9. Enilconazole sulfate Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline Sales
    • 9.2.1. Retail Stores
    • 9.2.2. Wholesalers
  • 9.3. Online Sales
    • 9.3.1. Company Websites
    • 9.3.2. E-Commerce Platforms

10. Americas Enilconazole sulfate Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Enilconazole sulfate Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Enilconazole sulfate Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ADAMA Agricultural Solutions Ltd.
  • 2. Albaugh, LLC
  • 3. American Vanguard Corporation
  • 4. Arysta LifeScience Corporation
  • 5. BASF SE
  • 6. Bayer AG
  • 7. Cheminova A/S
  • 8. Corteva Agriscience
  • 9. Dhanuka Agritech Limited
  • 10. Dow Chemical Company
  • 11. FMC Corporation
  • 12. Isagro SpA
  • 13. Koppert Biological Systems
  • 14. Marrone Bio Innovations, Inc.
  • 15. Nissan Chemical Corporation
  • 16. Nufarm Limited
  • 17. Sumitomo Chemical Co., Ltd.
  • 18. Syngenta AG
  • 19. UPL Limited
  • 20. Valent U.S.A. LLC
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦